Finasteride vs. Minoxidil for Hair Loss: Which Works Better?

Finasteride (oral, 1 mg/day, prescription) and minoxidil (topical 5%, over-the-counter) are the two FDA-approved first-line treatments for male androgenetic alopecia (AGA). They work through completely different mechanisms and can be used together. This page compares them side-by-side based on clinical evidence to help you and your physician make an informed treatment decision.

Head-to-Head Comparison

	Finasteride 1 mg (oral)	Minoxidil 5% (topical)
Mechanism	Inhibits Type II 5-alpha-reductase; reduces DHT ~70%	Potassium channel opener; vasodilator; extends anagen phase
FDA approval (male AGA)	Yes — 1997 (Propecia 1 mg)	Yes — 1988 (Rogaine 5% foam/solution)
Prescription required	Yes (Rx only)	No (OTC)
Administration	1 tablet once daily, oral	Applied to scalp once (foam) or twice daily
Hair loss halted at 12 months	~83% of men (Kaufman et al., 1998)	~60–67% of men (Olsen et al., 2002)
Visible regrowth at 12 months	~48% at vertex (vs. 7% placebo)	~40–48% some regrowth (vs. 13% placebo)
Onset of visible results	3–6 months (stabilization); 6–12 months (regrowth)	4–8 months
Best for	Vertex and mid-scalp; frontal slow-down	Vertex; diffuse thinning
Primary side effects	Sexual dysfunction (1–2% above placebo); rare PFS after stopping	Scalp irritation; initial shedding (2–8 weeks); systemic absorption (rare)
Teratogenicity	Yes — Pregnancy Category X; women must not handle crushed tablets	Not classified as teratogenic in standard use; avoid in pregnancy as precaution
Monthly cost (generic)	$15–$35	$10–$20 (5% topical OTC)
Combination therapy evidence	Yes — superior to either alone (Badri et al., 2021 meta-analysis)
Effect if stopped	Hair loss resumes within 6–12 months	Hair loss resumes within 3–6 months

Different Mechanisms — Why Both Can Be Used Together

The most important thing to understand about finasteride vs. minoxidil is that they attack hair loss from completely different angles:

• Finasteride works hormonally. It blocks the enzyme that converts testosterone to DHT, the androgen that drives follicle miniaturization in genetically susceptible men. It addresses the root hormonal cause of AGA.
• Minoxidil works mechanically. It opens ATP-sensitive potassium channels in vascular smooth muscle, increasing blood flow to follicles and extending the anagen (growth) phase. It does not affect DHT.

Because they act independently, combining them is additive rather than redundant. A 2021 systematic review and meta-analysis (Badri et al.) found that combination finasteride + minoxidil produced statistically significantly greater improvements in hair density and thickness compared to either agent alone, without a meaningful increase in side effects.

Clinical Efficacy in Detail

Finasteride Efficacy Data

From the pivotal Phase III trial (Kaufman et al., 1998; n=1,553 men, 1 year, double-blind, placebo-controlled):

• Hair count at the vertex increased by a mean of +7.1 hairs/cm² in the finasteride group vs. a decrease of −10.6 hairs/cm² in the placebo group
• 83% of finasteride-treated men had no further hair loss at 12 months vs. 28% on placebo
• At 5 years, finasteride-treated men had a mean of 277 more hairs/cm² (in a 1-inch disk) compared to men who had taken placebo throughout

Minoxidil Efficacy Data

From a pivotal controlled trial of 5% topical minoxidil (Olsen et al., 2002; n=393 men, 48 weeks):

• 5% minoxidil foam was statistically superior to placebo in hair regrowth at the vertex at 16 and 48 weeks
• Mean hair count increase: +17.7 hairs vs. +3.2 for placebo at 48 weeks (5% foam)
• 5% solution was superior to 2% solution and superior to placebo in all efficacy measures

Direct head-to-head RCTs comparing finasteride and minoxidil as monotherapies are limited. Available comparative data generally show finasteride producing superior or at least equivalent results at 12 months, particularly at the vertex. However, individual responses vary considerably.

Side Effects Compared

Finasteride Side Effects

The most reported adverse effects are sexual: decreased libido (1.8% vs. 1.3% placebo), erectile dysfunction (1.3% vs. 0.7%), and reduced ejaculate volume (0.8% vs. 0.4%). These occur in a small minority of men and typically resolve with discontinuation. The 2012 FDA label update added a warning about the possibility that sexual side effects may persist after stopping in some men (Post-Finasteride Syndrome). See our full PFS review.

Minoxidil Side Effects

The most common side effect of topical minoxidil is scalp irritation, dryness, or flaking, often attributable to propylene glycol in liquid formulations (less common with foam). Initial shedding occurs in some users 2–8 weeks after starting treatment as follicles synchronize into the growth phase — this is normal and temporary. Systemic absorption from topical application is generally minimal, but rare cases of hypotension, tachycardia, or fluid retention have been reported with very high-dose topical use.

Oral minoxidil (0.625–2.5 mg daily, off-label for hair loss) has a different side effect profile: fluid retention and hypertrichosis (unwanted body hair growth) are the main concerns. This is distinct from topical minoxidil.

Which Should You Choose?

There is no single right answer — the best choice depends on your individual circumstances, discussed with your physician. Some guidance:

Situation	Likely preferred starting point
Early-stage hair loss, want to address root hormonal cause	Finasteride (addresses DHT mechanism)
Cannot take oral prescription medication; want OTC option	Minoxidil (topical, OTC)
Concerned about sexual side effects	Start with minoxidil; discuss finasteride risk-benefit with physician
Moderate to advanced loss; want maximum evidence-based benefit	Combination (finasteride + minoxidil)
Women with AGA (off-label context)	Minoxidil (topical) is the standard first-line; finasteride is off-label (not FDA-approved for women)
BPH as well as hair loss	Finasteride 5 mg (addresses both; discuss with urologist)

Frequently Asked Questions

Can I use finasteride and minoxidil together?

Yes, and this is a common and evidence-backed approach. The two drugs work through different mechanisms (DHT suppression vs. direct follicle stimulation), so their effects are complementary and additive. A 2021 meta-analysis (Badri et al.) found combination therapy produced significantly greater improvements in hair density than either monotherapy alone. Both drugs are continued simultaneously; there are no significant pharmacokinetic interactions between them.

Does finasteride work better than minoxidil?

In most direct comparisons, finasteride produces equal or superior hair count and density improvements at 12 months, particularly at the vertex. However, individual responses vary. Some men respond better to one than the other. Finasteride has a stronger evidence base for long-term maintenance (5-year and 10-year data), while minoxidil has the advantage of being available OTC without a prescription and without the systemic hormonal mechanism. For most men with AGA, combining both is the most evidence-supported strategy.

Which works faster — finasteride or minoxidil?

Neither is particularly fast. Both require 3–6 months before any visible stabilization is evident, and 6–12 months for visible improvement in most responders. Minoxidil may produce slightly earlier initial results in some patients due to its direct follicle stimulation mechanism, but the difference is not clinically significant in practice. Both require continuous daily use to maintain benefit.

Is minoxidil safer than finasteride?

The two drugs have different safety profiles rather than one being categorically “safer.” Minoxidil avoids the systemic hormonal effects of finasteride and the associated sexual side effects. Finasteride avoids the scalp irritation and initial shedding common with topical minoxidil. The rare, persistent sexual side effects associated with finasteride are a concern for some men that do not apply to topical minoxidil. However, finasteride has a 25-year safety record and the absolute incidence of serious adverse effects is low. Both are considered generally safe for healthy adult men when used as directed.

Sources

• Kaufman KD, et al. “Finasteride in the treatment of men with androgenetic alopecia.” J Am Acad Dermatol. 1998;39(4):578–589.
• Olsen EA, et al. “A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.” J Am Acad Dermatol. 2002;47(3):377–385.
• Badri T, Nessel TA, Kumar D. “Minoxidil.” StatPearls. 2024.
• Piraccini BM, Blume-Peytavi U, Scarci F, et al. “Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial.” J Eur Acad Dermatol Venereol. 2022;36(2):286–294.